Indication
Acute T-Lymphocytic Leukemia
1 clinical trial
1 product
Clinical trial
Venetoclax Based Regimen for the Treatment of Relapsed or Refractory T-cell Acute Lymphoblastic LeukemiaStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Venetoclax